Symphony Environmental link dedicated website and twitter for commercialisation of SYM FRESH
Web: sym-fresh.net/ Twitter: twitter.com/symfresh SYM Fresh bags can keep your fruit and vegetables crisp'n'fresh for longer #symfresh #symfreshbags *Brand new product from Symphony Environmental
miagi365 said "....doesn't treat them so well after he's sold though!" And there it is. You have a gripe. Be adult. Accept responsibility for your investment choices. You seem obsessed with someone you clearly don't like. Odd.
Name me anyone who alerts everyone to a recommended stock [after investing time researching it] and then waits until everyone has purchased it before buying it themselves. Don't expect JW - or anyone else - to do that which you wouldn't do yourself. Please let us all know when you're about to sell your stocks - give us all three days warning before you press 'sell'. Yeh, that's gonna happen. ;)
It's normal for SO4 to halt trading on ASX pending capital raise announcement. Unfortunate that it comes at a time some UK investors concerned about debt resolution and financial close. Not the best of news [capital raise] - with AIM trading. Investing; keeps you on your toes. No doubt about it :)
Congrats to those holding. Really promising set of figures. Well deserved. Looks like ITX are finally coming through. Very straight-forward BoD who just get on the with job. I held between 2.2. and 3.4. No spare funds at present. I shall keep it on the watchlist and take a nibble later.
..will be getting exciting at this level. He'll be rewarded with cheap shares @ 25/30/35 for his work on the database. Without hitting those levels he effectively goes unrewarded. And that's not going to happen.
Rolling review to support emergency release of covid vaccine before Xmas. Coming weeks/months could see some money transferring into SO4 by investors exiting some over-priced covid favourites. Expecting SO4 to be one of a few PI post-covid favourites 2021. Fingers crossed.
re: The European Medicines Agency is expected to announce the 'rolling review' as soon as this week Such assessments are used in emergencies to allow regulators to see trial data while the development is ongoing to speed up approvals of drugs and vaccines that are urgently needed